Clinical Trial Update: Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM

View source ↗

Summary

A study investigating an individualized frailty-tailored therapy (DynaFiT) for elderly patients with newly diagnosed multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: FengYan Jin | Conditions: Multiple Myeloma, Frailty | Status: RECRUITING